Analysis via the TISCH2 database indicated predominant expression of RAD51 in Tprolif and malignant cell clusters, suggesting its involvement in promoting OSCC progression through regulation of malignant phenotypes and remodelling of the tumour microenvironment (TME). The gene discussed is RAD51; the disease is neoplasm.